Skip to main content

News

ABS Press Releases

Advanced Bifurcation Systems Inc. Acquires Svelte Medical Systems, Inc.

April 26, 2026
ABS today announced that it has recently acquired all assets of Svelte Medical Systems, Inc. (“Svelte”). The acquired portfolio includes Svelte’s drug-eluting coronary stents, all intellectual property, and the related comprehensive set of US and international regulatory approvals and filings.
Read More

Advanced Bifurcation Systems Inc. Secures $20.8 Million in Financing and Expands Board of Directors

January 17, 2025
ABS closed an oversubscribed $20.8 million SAFE financing round, with significant interest from investors worldwide. The company also welcomed Malia Chui and Susan Yashar to its Board, both bringing strategic expertise to support regulatory navigation and global expansion.
Read More

Advanced Bifurcation Systems Inc. Receives FDA Breakthrough Device Designation

October 23, 2023
Advanced Bifurcation Systems (ABS) announced its coronary artery bifurcation stenting technology received the FDA’s Breakthrough Device Designation. This milestone recognizes the device’s potential to revolutionize coronary treatments by simplifying procedures, improving patient outcomes, and reducing healthcare costs.
Read More